PAI
MEDP icon

Pittenger & Anderson Inc’s Medpace MEDP Stock Holding History

Pittenger & Anderson Inc’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$97K Sell
202
-1,574
-89% -$806K ﹤0.01% 272
2025
Q4 		$997K Buy
+1,776
New +$1.01M 0.04% 170
2024
Q4 		– Sell
-552
Closed -$184K – 455
2024
Q3 		$184K Buy
552
+295
+115% +$112K 0.01% 235
2024
Q2 		$106K Buy
+257
New +$102K ﹤0.01% 261

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Pittenger & Anderson Inc's MEDP Position: Q1 2026 in Review

Pittenger & Anderson Inc reduced its Medpace (MEDP) stake by 89% in Q1 2026, selling an estimated $806K and leaving 202 shares worth $97K. The position accounts for ﹤0.01% of the portfolio, ranked #272.

Pittenger & Anderson Inc first reported a position in MEDP in Q2 2024 and has held it in 4 quarters since. The position peaked at $997K in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Pittenger & Anderson Inc held 202 shares of Medpace worth $97K as of Q1 2026.
  • Pittenger & Anderson Inc sold 1,574 Medpace shares in Q1 2026, an estimated $806K.
  • Medpace made up ﹤0.01% of Pittenger & Anderson Inc's portfolio in Q1 2026, its #272 holding.
  • Pittenger & Anderson Inc first reported a position in Medpace in Q2 2024 and has held it in 4 quarters since.
  • Pittenger & Anderson Inc's Medpace position peaked at $997K in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Pittenger & Anderson Inc's 13F filing for Q1 2026, filed 1 May 2026.